The Pharmacy and Therapeutics (P&T) Committee is responsible for developing and maintaining medications and related products listed on the Ohio Department of Medicaid’s (ODM) Unified Preferred Drug List (UPDL) pursuant to the Ohio Revised Code § 5164.7510. The UPDL is maintained through a review of current evidence-based medicine and based upon the professional judgment of physicians, pharmacists, and other experts that participate in ODM’s Pharmacy and Therapeutics (P&T) Committee. The UPDL list can be found under the Drug Coverage tab.
The P&T Committee is composed of ten members appointed by the Medicaid Director. The P&T Committee members meet four times per year-including an annual review of the entire UPDL. Topics that may be discussed at meetings include:
- New brand or generic drugs
- UPDL changes based on any local or national issues (including contract issues)
- Stakeholder feedback through a Public Comment session
The members of the P&T Committee are:
- Susan K. Baker, CNP; Family Nurse Practitioner Liaison, Ohio Nurses Association
- Scott Baran, RPh; Ohio Department of Medicaid
- Mary Ann Dzurec, PharmD; Liaison, Ohio Pharmacists Association
- Suzanne Eastman, RPh, MS, Vice Chair; Liaison, Ohio Pharmacists Association
- Jennfier Gwilym, DO; Specialty Family Medicine; Liaison, Ohio Osteopathic Association
- Stephen Hersey, MD; Liaison, American Academy of Pediatrics
- Karen Jacobs, DO, Chair; Specialty Psychiatry; Liaison, Ohio Psychiatric Physicians Association
- Melissa Jefferis, MD; Specialty Family Medicine; Liaison, Ohio Academy of Family Physicians
- Nathan Samsa, D.O, Pharm.D., F.A.C.O.I.; Ohio Osteopathic Association